Skip to main content

Peer Review reports

From: Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison

Original Submission
1 Mar 2013 Submitted Original manuscript
11 Mar 2013 Author responded Author comments - Jorgen Moller
Resubmission - Version 2
11 Mar 2013 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
10 Sep 2013 Reviewed Reviewer Report - Yen Kuang Yang
22 Nov 2013 Reviewed Reviewer Report - Sang-Hyuk Lee
27 Feb 2014 Author responded Author comments - Jorgen Moller
Resubmission - Version 4
27 Feb 2014 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
12 Mar 2014 Reviewed Reviewer Report - Yen Kuang Yang
20 May 2014 Reviewed Reviewer Report - Gianluca Baio
23 Sep 2014 Author responded Author comments - Jorgen Moller
Resubmission - Version 6
23 Sep 2014 Submitted Manuscript version 6
Publishing
15 Oct 2014 Editorially accepted
2 Dec 2014 Article published 10.1186/s12888-014-0298-4

You can find further information about peer review here.

Back to article page